StockNews.AI
PETS
StockNews.AI
35 days

PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm

1. Bragar Eagel & Squire is investigating PetMed for possible legal violations. 2. PetMed's stock fell 11.22% following a delayed earnings announcement. 3. Investors are encouraged to discuss their legal rights regarding losses. 4. The firm specializes in representing investors in securities litigation. 5. No historical examples of similar investigations resulting in positive stock movements.

4m saved
Insight
Article

FAQ

Why Bearish?

The investigation and stock price drop signal potential ongoing issues for PetMed, increasing investor uncertainty; historically, legal investigations have adversely affected stock prices of other companies—e.g., Theranos, whose legal troubles led to a sharp stock decline.

How important is it?

Ongoing legal scrutiny is highly relevant for PETS, signaling potential further regulatory challenges and investor skepticism.

Why Short Term?

Immediate investor sentiment may worsen as more details about the investigation emerge, paralleling past examples like Enron, which faced rapid short-term declines upon legal announcements.

Related Companies

HLITRADVYST
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in PetMed and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) on behalf of PetMed stockholders. Our investigation concerns whether PetMed has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On June 10, 2025, PetMed issued a press release "announc[ing] it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process." On this news, PetMed's stock price fell $0.47 per share, or 11.22%, to close at $3.72 per share on June 11, 2025. If you purchased or otherwise acquired PetMed shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News